Heart imaging study for cardiac amyloidosis detection
Part of Brain & nervous system, Genetic & congenital, Heart & circulation, Hormones & metabolism, Injuries & trauma clinical trials.
This study uses a special heart ultrasound to look for signs of cardiac amyloidosis, a condition where abnormal proteins build up in the heart. It may help diagnose the condition earlier and guide treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must not have a known diagnosis of cardiac amyloidosis.
- You must have a heart ultrasound that gives clear images for the study.
- You must be able to provide written consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how cardiac amyloidosis shows up on heart imaging, especially ultrasound (echocardiography). It may help doctors better describe and track the condition using your exam and test results.
This trial tests an AI program that looks at your heart ultrasound (echocardiogram) to find possible signs of cardiac amyloidosis early. It helps doctors decide if more testing is needed.
This study tests whether an artificial-intelligence system can help decide who should get a special heart workup for a rare disease called cardiac amyloidosis. If you have signs that make doctors suspect this, the AI-guided ultrasound screening may help find it sooner.
This study uses special heart tests (AI-ECG and CT scan) to look for a hidden condition called cardiac amyloidosis, which can affect people with atrial fibrillation. Finding it early may help guide treatment and improve outcomes.
This study uses signals from a pacemaker or defibrillator to help detect a condition called cardiac amyloidosis, where abnormal proteins build up in the heart. It may help diagnose this condition earlier without extra tests.
This trial is testing older adults with heart failure to see if a heart condition called cardiac amyloidosis (a buildup of abnormal protein in the heart) is present. If you are 80 or older, have been in the hospital for heart failure in the past year, and have a thickened heart wall, you may be able to join.
Hear when a new Cardiac Amyloidosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.